Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Evolution and Validation of Thyroid Cancer Guidelines as Evidence Advances Toward Individualized Therapy.

The Journal of clinical endocrinology and metabolism·2026
Same author

DLL3 Expression in a Genotyped Cohort of Sporadic Medullary Thyroid Carcinomas.

The American journal of surgical pathology·2026
Same author

Neuroinvasion pathways of Treponema denticola and its role in amyloidogenesis and neuroinflammation: A systematic review.

Microbial pathogenesis·2026
Same author

Clinicopathologic and Molecular Features of Poorly Differentiated Thyroid Carcinomas in Adults ≤ 45 Years of Age.

Endocrine pathology·2026
Same author

Counseling Female Thyroid Cancer Patients on Radioactive Iodine and Fertility.

Thyroid : official journal of the American Thyroid Association·2026
Same author

Sense of Belonging from Celebrated Identity: Getting to Know Interns Through Surgical Grand Rounds.

Journal of surgical education·2026

Related Experiment Video

Updated: Mar 12, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K

Hürthle cell carcinoma: current perspectives.

Sara Ahmadi1, Michael Stang2, Xiaoyin Sara Jiang3

  • 1Division of Endocrinology, Department of Medicine.

Oncotargets and Therapy
|November 18, 2016
PubMed
Summary

Hürthle cell carcinoma (HCC) is an aggressive thyroid cancer. While minimally invasive cases may be treated with surgery alone, radioactive iodine (RAI) can improve survival for larger tumors or those with metastases.

Keywords:
Hurthle cell lesionfollicular cell carcinomaminimally invasive HCCthyroid cancerthyroid nodule

More Related Videos

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

11.5K
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

9.1K

Related Experiment Videos

Last Updated: Mar 12, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

11.5K
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

9.1K

Area of Science:

  • Oncology
  • Endocrinology
  • Surgical Oncology

Background:

  • Hürthle cell carcinoma (HCC) is a subtype of differentiated thyroid cancer.
  • HCC typically exhibits more aggressive behavior and a higher propensity for distant metastases compared to other differentiated thyroid cancers.
  • Minimally invasive HCC (<4 cm) can often be managed with thyroid lobectomy alone, potentially avoiding radioactive iodine (RAI) therapy.

Approach:

  • Evaluating the clinical behavior and treatment strategies for Hürthle cell carcinoma.
  • Assessing the efficacy of radioactive iodine (RAI) in managing HCC based on tumor size and metastatic status.
  • Considering localized therapies for iodine-resistant disease and systemic therapy for advanced metastatic HCC.

Key Points:

  • Hürthle cell carcinoma (HCC) generally presents with more aggressive behavior and higher rates of distant metastasis than other differentiated thyroid cancers.
  • While smaller, minimally invasive HCC (<4 cm) may be treated with thyroid lobectomy alone without RAI, recent data suggest improved survival with RAI for HCC >2 cm or with nodal/distant metastases.
  • Localized therapies are options for iodine-resistant disease not suitable for observation, while systemic therapy is reserved for progressive, widely metastatic HCC.

Conclusions:

  • Treatment decisions for Hürthle cell carcinoma should be individualized based on invasiveness, tumor size, and metastatic potential.
  • Radioactive iodine (RAI) may play a beneficial role in specific Hürthle cell carcinoma patient groups, challenging previous assumptions of universal iodine resistance.
  • A multi-modal approach, including surgery, RAI, localized therapies, and systemic therapy, is crucial for managing the spectrum of Hürthle cell carcinoma presentations.